AdvaVet

AdvaVet is a clinical-stage veterinary pharmaceutical company dedicated to developing and commercializing innovative medicines for companion animals. The company focuses on repurposing proven human therapeutics for use in dogs and cats, targeting significant unmet needs in veterinary oncology and pain management. By leveraging the FDA's Minor Use and Minor Species (MUMS) designation and other expedited regulatory pathways, AdvaVet aims to bring high-quality treatments to market more efficiently. Their lead programs include advanced formulations for treating canine lymphoma and osteosarcoma, as well as therapies for chronic pain and inflammation. AdvaVet's mission is to extend and improve the quality of life for pets through evidence-based veterinary medicine.